Valuation: Compumedics Limited

Market Cap 49.94M 35.09M 31.27M 28.95M 26.2M 49.36M 3.31B 347M 136M 1.74B 132M 129M 5.55B P/E 2027 *
11.9x
P/E 2028 * 7.81x
Enterprise Value 49.94M 35.09M 31.27M 28.95M 26.2M 49.36M 3.31B 347M 136M 1.74B 132M 129M 5.55B EV / Sales 2027 *
0.66x
EV / Sales 2028 * 0.55x
Free-Float
36.04%
Yield 2027 *
-
Yield 2028 * -
1 day-4.00%
1 week-2.04%
3 months+4.35%
6 months-18.64%
Current year-28.36%
1 week 0.24
Extreme 0.24
0.25
1 month 0.22
Extreme 0.225
0.28
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.45
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 2010-12-15
Director of Finance/CFO 61 2009-11-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 2010-12-15
Director/Board Member 61 1999-12-31
Director/Board Member - 2022-10-26
Change 5-day change 1-year change 3-year change Capi.($)
-4.00%-2.04%-40.00%+54.84% 35.09M
+0.97%+3.09%+24.38%+49.46% 257B
+4.29%+4.08%+5.93%+13.62% 164B
-2.26%+1.88%-7.48%+60.40% 151B
-2.35%+3.51%-55.45%-11.07% 64.51B
+0.35%+2.50%-15.14%-10.86% 52.1B
+0.59%+7.80%+10.60%+59.96% 51.9B
+0.12%+2.26%+16.29%+27.23% 50.95B
+2.74%+2.16%+22.01%+62.73% 50.11B
+3.31%+4.78%+30.99%+80.36% 44.95B
Average +0.06%+3.68%-0.79%+38.67% 88.68B
Weighted average by Cap. +0.43%+3.50%+6.32%+38.39%

Financials

2027 *2028 *
Net sales 75.6M 53.12M 47.33M 43.82M 39.66M 74.71M 5.01B 525M 206M 2.63B 199M 195M 8.4B 91M 63.94M 56.97M 52.75M 47.74M 89.93M 6.03B 632M 248M 3.17B 240M 235M 10.11B
Net income 6M 4.22M 3.76M 3.48M 3.15M 5.93M 398M 41.7M 16.36M 209M 15.81M 15.48M 666M 9.2M 6.46M 5.76M 5.33M 4.83M 9.09M 610M 63.94M 25.09M 321M 24.25M 23.74M 1.02B
Net Debt - -
Projected Income Statement - Annual - Compumedics Limited
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
26-10-21 A$0.2400 -4.00% 6,350
26-10-21 A$0.2500 +2.04% 127,536
26-10-20 A$0.2450 +2.08% 4,040
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Compumedics Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2500AUD
Average target price
0.6500AUD
Spread / Average Target
+160.00%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Compumedics Limited